Journal
CHEMISTRY & BIOLOGY
Volume 19, Issue 4, Pages 456-466Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2012.01.017
Keywords
-
Categories
Funding
- Defense Threat Reduction Agency (DTRA) of the US Department of Defense [HDTRA1-07-C-0024]
- CounterACT Program
- National Institutes Of Health Office of the Director
- National Institute of Neurological Diseases and Stroke [U54-NS058183]
- Blanche foundation
Ask authors/readers for more resources
A preferred strategy for preventing nerve agents intoxication is catalytic scavenging by enzymes that hydrolyze them before they reach their targets. Using directed evolution, we simultaneously enhanced the activity of a previously described serum paraoxonase 1 (PON1) variant for hydrolysis of the toxic S-P isomers of the most threatening G-type nerve agents. The evolved variants show <= 340-fold increased rates and catalytic efficiencies of 0.2-5 x 10(7) M-1 min(-1). Our selection for prevention of acetylcholinesterase inhibition also resulted in the complete reversion of PON1's stereospecificity, from an enantiomeric ratio (E) < 6.3 x 10(-4) in favor of the R-P isomer of a cyclosarin analog in wild-type PON1, to E > 2,500 for the S-P isomer in an evolved variant. Given their ability to hydrolyze G-agents, these evolved variants may serve as broad-range G-agent prophylactics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available